Local NSAID gel (Eltenac) in the treatment of osteoarthritis of the knee: A double blind study comparing eltenac with oral diclofenac and placebo gel

Scandinavian Journal of Rheumatology

Volumn 26, Issue 4, 1997, Pages 287-292

  Sandelin, J ^a   Harilainen, A ^a   Crone, H ^a   Hamberg, P ^a   Forsskahl B ^a   Tamelander, G ^a  

^a ORTON Invalid Foundation   (Finland)

Author keywords

Double blind study; NSAID gel; Oral diclofenac; Osteoarthritis; Placebo

Indexed keywords

DICLOFENAC; ELTENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; KNEE ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROTOXICITY; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030815114     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749709105318     Document Type: Article

References (24)

1. Haraoui B, Pelletier JP, Cloutier JM, Faure MP, Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis: in vivo effects of antirheumatic drugs. Arthritis Rheum 1991;34:153-63.
2. Revell PA, Mayston V, Lalor P, Mapp P. The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis 1988;47:300-7.
3. Lindblad S, Hedfors E. Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum 1987;30:1081-8.
4. Zeidler H. Epidemiology of NSAID induced gastropathy. J Rheumatol 1991;18 Suppl 28:2-5.
5. Beardon PHG, Brown SV, McDevitt DG. Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside. Q J Med 1989;71:497-505.
6. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987;147: 85-8.
7. NN. Topical NSAIDs: A gimmick or a godsend. Lancet 1989; 30:779-80.
8. Ritchie LD, Sugawara S, Ishigami M, Satoh Y, Suzuki K. Local action transcutaneous flurbiprofen (flurbiprofen LAT) in the treatment of acute musculoskeletal conditions: a review of European and Japanese experience. J Orthop Rheumatol 1995;8:134-9.
9. Study report FK-07/89 - Bioavailability of topically applied Eltenac- and Diclofenac-gel in healthy volunteers. Luitpold Pharma, Munich, Germany.
10. Study report FK-07/95 - Eltenac serum and urine concentrations in human volunteers after application of two different gel concentrations. A double-blind parallel group study; clinical report of October 1995 available, serum/urine analyses running/in preparation. Luitpold Pharma, Munich, Germany.
11. Ahlbäck S. Osteoarthrosis of the knee: a radiographic investigation. Acta Radiol Suppl 1968;277:7-72.
12. Altman RD. Classification of disease: Osteoarthritis. Semin Arthritis Rheum 1991;20 Suppl 2:40-7.
13. Lequesne MG, Mery C, Samson M, Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Validation - Value in comparison with other assessment tests. Scand J Rheumatol 1987;16 Suppl 65:85-9.
14. ® with oral indomethacin and placebo. Int J Sports Med 1990;11:393-6.
15. Springorum HW, Guzik A, Schmid K. Proglumetacin versus Diclofenac bei aktivierter Gonarthrose. Rheuma 1992;12(2): 62-5.
16. Bellamy N, Kean WF, Buchanan WW, Gerecz-Simon E, Campbell J. Double blind randomized controlled trial of sodium meclofenamate (meclomen) and diclofenac sodium (voltaren): Post validation reapplication of the WOMAC osteoarthritis index. J Rheumatol 1992;19:153-9.
17. Bakshi R, Ezzet N, Frey L, Lasry D, Salliere D. Efficacy and tolerability of diclofenac dispersible in painful osteoarthrosis. Clin Rheumatol 1993;12(1):57-61.
18. Lohmander LS, Dalén N, Englund G, Hämäläinen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Ann Rheum Dis 1996;55:424-31.
19. Puhl W, Bernau A, Greiling H, Kopeke W, Pförringer W, Steck KJ, et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter double-blind study. Osteoarthritis Cartilage 1993;1:233-41.
20. Study report FK-05/93 - Efficacy and safety of Eltenac gel in the treatment of knee osteoarthritis. A double-blind dose-finding pilot study; draft of 19 April 1996. Luitpold Pharma, Munich, Germany.
21. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8.
22. Evans JMM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ 1995;311:22-6.
23. Study report FK-02/94 - Eltenac gel in soft tissue rheumatism. Placebo controlled randomized multicenter doubleblind study on efficacy and tolerance in patients with bursitis, tendinitis or tendovaginitis; final version of 26.4.96. Luitpold Pharma, Munich, Germany.
24. Rosemeyer B. Behandlung von Distorsionen des Sprunggelenkes. Piroxicam-Gel versus Diclofenac-Gel. Med Welt 1991;42:166-70.